Interpretable multitemporal liver function indicator model for prediction and risk factor analysis of drug induced liver injury.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
12 Sep 2024
12 Sep 2024
Historique:
received:
03
12
2023
accepted:
05
07
2024
medline:
12
9
2024
pubmed:
12
9
2024
entrez:
11
9
2024
Statut:
epublish
Résumé
The occurrence of liver injury during cancer treatment is extremely harmful. The risk factors for drug.induced liver injury (DILI) in the pancreatic cancer population have not been investigated. This study aims to develop and validate an interpretable decision tree (DT) model for the early prediction of DILI in pancreatic cancer patients using multitemporal clinical data and screening for related risk factors. A retrospective collection of data was conducted on 307 patients, the training set (n = 215) was used to develop the model, and the test set (n = 92) was used to evaluate the model. The classification and regression trees algorithm was employed to establish the DT model. The Shapley Additive explanations (SHAP) method was used to facilitate clinical interpretation. Model performance was assessed using AUC and the Hosmer‒Lemeshow test. The DT model exhibited superior diagnostic efficacy, the AUC values were 0.995 and 0.994 in the training and test sets, respectively. Four risk factors associated with DILI occurrence were identified: delta.albumin, delta.ALT, and post (AST: ALT), and post.GGT. The multiperiod liver function indicator.based interpretable DT model predicted DILI occurrence in the pancreatic cancer population and contributes to personalized clinical management of pancreatic cancer patients.
Identifiants
pubmed: 39261535
doi: 10.1038/s41598-024-66952-8
pii: 10.1038/s41598-024-66952-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
21285Subventions
Organisme : Education Department of Hangzhou City, Zhejiang Province Program
ID : Y202249209
Organisme : Education Department of Hangzhou City, Zhejiang Province Program
ID : Y202249209
Organisme : Education Department of Hangzhou City, Zhejiang Province Program
ID : Y202249209
Organisme : Education Department of Hangzhou City, Zhejiang Province Program
ID : Y202249209
Organisme : Education Department of Hangzhou City, Zhejiang Province Program
ID : Y202249209
Informations de copyright
© 2024. The Author(s).
Références
Shubert, C. R. et al. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the national cancer database. Surgery 160, 1080 (2016).
doi: 10.1016/j.surg.2016.06.010
pubmed: 27522556
Duwe, G. et al. Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection. Ejso-Eur. J. Surg. Onc. 43, 1668 (2017).
doi: 10.1016/j.ejso.2017.05.008
Shen, T. et al. Incidence and etiology of drug-induced liver injury in Mainland China. Gastroenterology 156, 2230 (2019).
doi: 10.1053/j.gastro.2019.02.002
pubmed: 30742832
Floyd, J., Mirza, I., Sachs, B. & Perry, M. C. Hepatotoxicity of chemotherapy. Semin. Oncol. 33, 50 (2006).
doi: 10.1053/j.seminoncol.2005.11.002
pubmed: 16473644
Wang, C. et al. Neoadjuvant therapy for pancreatic ductal adenocarcinoma: Where do we go?. Front. Oncol. 12, 828223 (2022).
doi: 10.3389/fonc.2022.828223
pubmed: 35785193
pmcid: 9245892
Scheufele, F., Hartmann, D. & Friess, H. Treatment of pancreatic cancer-neoadjuvant treatment in borderline resectable/locally advanced pancreatic cancer. Transl. Gastroent. Hep. 4, 32 (2019).
doi: 10.21037/tgh.2019.04.09
Klaiber, U. & Hackert, T. Conversion surgery for pancreatic cancer-the impact of neoadjuvant treatment. Front. Oncol. 9, 1501 (2019).
doi: 10.3389/fonc.2019.01501
pubmed: 31993372
Gangi, A. & Lu, S. C. Chemotherapy-associated liver injury in colorectal cancer. Ther. Adv. Gastroenter. 13, 320854238 (2020).
doi: 10.1177/1756284820924194
Yu, Y. C. et al. CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol. Int. 11, 221 (2017).
doi: 10.1007/s12072-017-9793-2
pubmed: 28405790
Andrade, R. J. et al. EASL clinical practice guidelines: drug-induced liver injury. J. Hepatol. 70, 1222 (2019).
doi: 10.1016/j.jhep.2019.02.014
Senior, J. R. Monitoring for hepatotoxicity: What is the predictive value of liver “function” tests?. Clin. Pharmacol. Ther. 85, 331 (2009).
doi: 10.1038/clpt.2008.262
pubmed: 19129750
Teschke, R. & Frenzel, C. Drug induced liver injury: do we still need a routine liver biopsy for diagnosis today?. Ann. Hepatol. 13, 121 (2013).
doi: 10.1016/S1665-2681(19)30913-5
pubmed: 24378275
Skrdla, P. J., Coscia, B. J., Gavartin, J., Browning, A. & Shelley, J. Drug aggregation of sparingly-soluble ionizable drugs: molecular dynamics simulations of papaverine and prostaglandin F2α. Mol. Pharm. 20(10), 5135–5147 (2023).
doi: 10.1021/acs.molpharmaceut.3c00429
pubmed: 37671526
Zhou, L. Q. et al. Artificial intelligence in medical imaging of the liver. World J. Gastroentero. 25, 672 (2019).
doi: 10.3748/wjg.v25.i6.672
Dickinson, Q. & Meyer, J. G. Positional SHAP (PoSHAP) for Interpretation of machine learning models trained from biological sequences. PLOS Comput. Biol. 18, e1009736 (2022).
doi: 10.1371/journal.pcbi.1009736
pubmed: 35089914
pmcid: 8797255
Hammann, F. & Drewe, J. Decision tree models for data mining in hit discovery. Expert Opin. Drug Dis. 7, 341 (2012).
doi: 10.1517/17460441.2012.668182
Churpek, M. M. et al. Multicenter comparison of machine learning methods and conventional regression for predicting clinical deterioration on the wards. Crit. Care Med. 44, 368 (2016).
doi: 10.1097/CCM.0000000000001571
pubmed: 26771782
pmcid: 4736499
Asai, Y., Ooi, H. & Sato, Y. Risk evaluation of carbapenem-induced liver injury based on machine learning analysis. J. Infect. Chemother. 29, 660 (2023).
doi: 10.1016/j.jiac.2023.03.007
pubmed: 36914094
Strobel, O. et al. Resection after neoadjuvant therapy for locally advanced, “unresectable” pancreatic cancer. Surgery 152, S33 (2012).
doi: 10.1016/j.surg.2012.05.029
pubmed: 22770956
Bjornsson, E. S. et al. A new framework for advancing in drug-induced liver injury research. The prospective European DILI registry. Liver Int. 43, 115 (2023).
doi: 10.1111/liv.15378
pubmed: 35899490
Chalasani, N. P., Maddur, H., Russo, M. W., Wong, R. J. & Reddy, K. R. ACG Clinical guideline: Diagnosis and management of idiosyncratic drug-induced liver injury. Am. J. Gastroenterol. 116, 878 (2021).
doi: 10.14309/ajg.0000000000001259
pubmed: 33929376
Han, Z. et al. Delta-radiomics models based on multi-phase contrast-enhanced magnetic resonance imaging can preoperatively predict glypican-3-positive hepatocellular carcinoma. Front Physiol. 14, 1138239 (2023).
doi: 10.3389/fphys.2023.1138239
pubmed: 37601639
pmcid: 10435992
Zhu, Y. & Wang, M. C. Obtaining optimal cutoff values for tree classifiers using multiple biomarkers. Biometrics 78, 128 (2022).
doi: 10.1111/biom.13409
pubmed: 33249556
Shi, K. Q. et al. Classification and regression tree analysis of acute-on-chronic hepatitis B liver failure: Seeing the forest for the trees. J Viral Hepat. 24, 132 (2017).
doi: 10.1111/jvh.12617
pubmed: 27686368
Rutkowski, L., Jaworski, M., Pietruczuk, L. & Duda, P. A new method for data stream mining based on the misclassification error. IEEE T Neur. Net. Lear. 26, 1048 (2015).
Rau, C. S. et al. Identification of pancreatic injury in patients with elevated amylase or lipase level using a decision tree classifier: A cross-sectional retrospective analysis in a level I trauma center. Int. J. Environ. Res. Pub. Health 15(2), 277 (2018).
doi: 10.3390/ijerph15020277
Davidson, S. M. et al. Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors. Nat. Med. 23, 235 (2017).
doi: 10.1038/nm.4256
pubmed: 28024083
Katayama, K. Zinc and protein metabolism in chronic liver diseases. Nutr. Res. 74, 1 (2020).
doi: 10.1016/j.nutres.2019.11.009
pubmed: 31891865
Sun, L. et al. Impaired albumin function: a novel potential indicator for liver function damage?. Ann. Med. 51, 333 (2019).
doi: 10.1080/07853890.2019.1693056
pubmed: 31714153
pmcid: 7877890
Shi, H., Li, J. & Fu, D. Process of hepatic metastasis from pancreatic cancer: Biology with clinical significance. J. Cancer Res. Clin. 142, 1137 (2016).
doi: 10.1007/s00432-015-2024-0
Sookoian, S. & Pirola, C. J. Liver enzymes, metabolomics and genome-wide association studies: From systems biology to the personalized medicine. World J. Gastroentero. 21, 711 (2015).
doi: 10.3748/wjg.v21.i3.711
Park, H. N. et al. Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease. Liver Int. 32, 937 (2012).
doi: 10.1111/j.1478-3231.2011.02749.x
pubmed: 22260521
M’Kada, H. et al. Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: A prospective pilot cohort study. PLOS ONE 7, e42418 (2012).
doi: 10.1371/journal.pone.0042418
pubmed: 22905129
pmcid: 3419230
Weber, S., Allgeier, J., Denk, G. & Gerbes, A. L. Marked increase of gamma-glutamyltransferase as an indicator of drug-induced liver injury in patients without conventional diagnostic criteria of acute liver injury. Visc. Med. 38, 223 (2022).
doi: 10.1159/000519752
pubmed: 35814980
Chambers, P. et al. Personalising monitoring for chemotherapy patients through predicting deterioration in renal and hepatic function. Cancer Med. 12(17), 17856–17865 (2023).
doi: 10.1002/cam4.6418
pubmed: 37610318
pmcid: 10524043
Vallée, R. et al. Machine learning decision tree models for multiclass classification of common malignant brain tumors using perfusion and spectroscopy MRI data. Front. Oncol. 13, 1089998 (2023).
doi: 10.3389/fonc.2023.1089998
pubmed: 37614505
pmcid: 10442801
Sun, S. et al. Development and validation of machine-learning models for the difficulty of retroperitoneal laparoscopic adrenalectomy based on radiomics. Front. Endocrinol. 14, 1265790 (2023).
doi: 10.3389/fendo.2023.1265790